Herantis Pharma Oyj (HRTIS.HE)
EUR 1.66
(0.91%)
EUR 1.66
(0.91%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.74 Million EUR | 8.24% |
| 2022 | 623.21 Million EUR | 7929.3% |
| 2021 | 7.76 Million EUR | -52.73% |
| 2020 | 16.42 Million EUR | 48.32% |
| 2019 | 11.07 Million EUR | 54.89% |
| 2018 | 7.14 Million EUR | -38.24% |
| 2017 | 11.57 Million EUR | 13.4% |
| 2016 | 10.2 Million EUR | -27.56% |
| 2015 | 14.08 Million EUR | -52.23% |
| 2014 | 29.49 Million EUR | 1016.87% |
| 2013 | 2.64 Million EUR | 19.42% |
| 2012 | 2.21 Million EUR | 230.0% |
| 2011 | 670.13 Thousand EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.64 Million EUR | -45.92% |
| 2024 Q2 | 3.64 Million EUR | 0.0% |
| 2023 Q2 | 5.14 Million EUR | 0.0% |
| 2023 FY | 6.74 Million EUR | -98.92% |
| 2023 Q3 | 6.74 Million EUR | 31.21% |
| 2023 Q4 | 6.74 Million EUR | 0.0% |
| 2023 Q1 | 5.14 Million EUR | -17.51% |
| 2022 Q4 | 623.21 Million EUR | 9900.0% |
| 2022 Q3 | 6.23 Million EUR | -42.04% |
| 2022 FY | 623.21 Million EUR | 7929.3% |
| 2022 Q1 | 10.75 Million EUR | 38.54% |
| 2022 Q2 | 10.75 Million EUR | 0.0% |
| 2021 Q2 | 8.21 Million EUR | 0.0% |
| 2021 Q4 | 7.76 Million EUR | 0.0% |
| 2021 Q3 | 7.76 Million EUR | -5.47% |
| 2021 FY | 7.76 Million EUR | -52.73% |
| 2021 Q1 | 8.21 Million EUR | -49.99% |
| 2020 Q2 | 12.59 Million EUR | 0.0% |
| 2020 FY | 16.42 Million EUR | 48.32% |
| 2020 Q1 | 12.59 Million EUR | 13.8% |
| 2020 Q4 | 16.42 Million EUR | 0.0% |
| 2020 Q3 | 16.42 Million EUR | 30.34% |
| 2019 Q1 | 9.89 Million EUR | 38.43% |
| 2019 Q2 | 9.89 Million EUR | 0.0% |
| 2019 FY | 11.07 Million EUR | 54.89% |
| 2019 Q4 | 11.07 Million EUR | 0.0% |
| 2019 Q3 | 11.07 Million EUR | 11.88% |
| 2018 Q3 | 7.14 Million EUR | -24.16% |
| 2018 Q2 | 9.42 Million EUR | 0.0% |
| 2018 Q1 | 9.42 Million EUR | -18.56% |
| 2018 FY | 7.14 Million EUR | -38.24% |
| 2018 Q4 | 7.14 Million EUR | 0.0% |
| 2017 Q1 | 8.91 Million EUR | -12.61% |
| 2017 FY | 11.57 Million EUR | 13.4% |
| 2017 Q2 | 8.91 Million EUR | 0.0% |
| 2017 Q4 | 11.57 Million EUR | 0.0% |
| 2017 Q3 | 11.57 Million EUR | 29.76% |
| 2016 Q4 | 10.2 Million EUR | 0.0% |
| 2016 Q1 | 11.58 Million EUR | -17.79% |
| 2016 Q2 | 11.58 Million EUR | 0.0% |
| 2016 FY | 10.2 Million EUR | -27.56% |
| 2016 Q3 | 10.2 Million EUR | -11.89% |
| 2015 Q1 | 15.89 Million EUR | -46.09% |
| 2015 FY | 14.08 Million EUR | -52.23% |
| 2015 Q3 | 14.08 Million EUR | -11.39% |
| 2015 Q4 | 14.08 Million EUR | 0.0% |
| 2015 Q2 | 15.89 Million EUR | 0.0% |
| 2014 Q2 | 33.65 Million EUR | 1030.58% |
| 2014 Q3 | 29.49 Million EUR | -12.37% |
| 2014 FY | 29.49 Million EUR | 1016.87% |
| 2014 Q4 | 29.49 Million EUR | 0.0% |
| 2014 Q1 | 2.97 Million EUR | 12.73% |
| 2013 Q3 | 2.64 Million EUR | 0.0% |
| 2013 Q4 | 2.64 Million EUR | 0.0% |
| 2013 FY | 2.64 Million EUR | 19.42% |
| 2013 Q1 | 2.28 Million EUR | 0.0% |
| 2012 FY | 2.21 Million EUR | 230.0% |
| 2011 FY | 670.13 Thousand EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biohit Oyj | 12.9 Million EUR | 47.708% |
| Nanoform Finland Oyj | 78.13 Million EUR | 91.367% |